Abstract
Introduction Early child development sets the stage for lifelong health. Identifying early life factors related to child development can help guide programs and policies to bolster child health and wellbeing. The objective of this research was to examine how a broad range of predictors, measured prenatally to the third year of life, are related to child development at kindergarten.
Methods We linked survey data from the Manitoba site of the CHILD Cohort Study with data from the Early Development Instrument (EDI) assessment, completed in kindergarten by the Manitoba public school system (n=442 children). The EDI measures five domains of development (ex. language, physical), scored to indicate the bottom 10% (i.e. ‘vulnerable’) of the population on one or more domains. Using structural equation modelling, we grouped 23 predictors of child development into six latent factors including prenatal exposures, child health and lifestyle, family stress, and socioeconomic status. We examined the associations between each latent factor and EDI vulnerability.
Results Overall, 20.1% of children were vulnerable on one or more EDI domains. Higher family stress at 1 year and 3 years was related to a 0.20 (p-value ≤ 0.001) and 0.33 (p-value ≤ 0.001) standardized increase of EDI vulnerability. Higher socioeconomic status was related to a - 0.26 (p-value =0.01) standardized increase of EDI vulnerability, and this link was partially mediated through family stress at three years (10.6% mediated). Prenatal exposures (e.g. maternal diet quality), as well as child health and lifestyle factors (e.g. weekday sleep) were not related to EDI vulnerability.
Conclusions Supporting parental mental health throughout early life, universal screening for early life stress, as well as targeting programs and supports for those living with low SES appear to be priority areas that could help to improve early child development.
Competing Interest Statement
All author declare no financial relationships with any organizations that might have an interest in the submitted work in the previous three years and no other relationships or activities that could appear to have influenced the submitted work. Authors had the following grant support during the preparation of this manuscript: S.E. Turner is funded by the Canadian Institutes of Health Research (CIHR) as a Vanier Scholar. P.J.M. has active nominated principal investigator funding from CIHR, Women's and Children's Health Research Network, Public Health agency of Canada and Alberta Health. S.E. Turvey holds the Tier 1 Canada Research Chair in Pediatric Precision Health and the Aubrey J. Tingle Professor of Pediatric Immunology. P.S. holds the Tier 1 Canada Research Chair in Pediatric Asthma and Lung Health. M.B.A. holds the Tier 2 Canada Research Chair in Developmental Origins of Chronic Disease. She receives research funding from the Canadian Institutes of Health Research, the Canada Foundation for Innovation, the Bill and Melinda Gates Foundation, Research Manitoba, Mitacs, CIFAR, the Garfield Weston Foundation. She has consulted for DSM Nutritional Products and serves on the Malaika Vx and Tiny Health Scientific Advisory Boards. S.G, T.M., B.D., T. J. M., E.S., have no conflicts of interest relevant to this article to disclose.
Funding Statement
The Canadian Institutes of Health Research (CIHR) and the Allergy, Genes and Environment Network of Centers of Excellence (AllerGen NCE) provided core support for the CHILD study (grants to founding CHILD director Malcolm Sears and current director Dr. Subbarao).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Human Research Ethics Boards at McMaster University and the University of Manitoba gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
A list of variables available in the CHILD Cohort Study is available at https://childstudy.ca/for-researchers/study-data/. Researchers interested in collaborating on a project and accessing CHILD Cohort Study data should contact the Study's National Coordinating Centre (NCC) to discuss their needs before initiating a formal request. To contact the NCC, please email child@mcmaster.ca. More information about data access for the CHILD Cohort Study can be found at https://childstudy.ca/for-researchers/data-access/
